CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
Broccoli Sprouts +1 moredrug
Likely dose
Broccoli Sprouts 100gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01522703
NCT01522703N/ACompleted
CompareCT.gov

Dietary Interventions and Asthma Treatment: A Pilot Study of the Effects of Whole Sprouts on Airway Allergic Inflammation

Johns Hopkins University·interventional·Posted Feb 1, 2012·Updated Jan 19, 2017

In Brief

A clinical study evaluating Broccoli Sprouts and Placebo for Allergic Rhinitis and 2 related conditions. Completed, enrolled 51 participants across 1 site.

Detailed Summary

The primary objective of this study is to determine if broccoli sprouts (BS) improves airway inflammatory, oxidative stress (OS), and symptoms among asthmatic adults with aeroallergen sensitization. The study is a double-blind, placebo-controlled, randomized trial to compare BS to placebo in 40 adults with asthma. 40 adults (age 18-50) who meet these eligibility criteria will be randomized to receive either: (a) BS or (b) placebo (alfalfa sprouts). Subjects will eat a sprouts sandwich daily for three days, and then undergo repeat measurement of outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAllergic Rhinitis, Asthma, Allergy
CountriesUnited States
CollaboratorsNational Institute of Environmental Health Sciences (NIEHS)

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 1, 2012
Enrollment StartMar 1, 2012
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 14.4 years ago

Interventions

Broccoli Sproutsdrug

100g of either broccoli or alfalfa sprouts will be eaten daily in a sandwich or wrap form.

Placebodrug

Alfalfa Sprouts